Effect of L-arginine versus control group on the prevention of preeclampsia in primiparous pregnant wome
Phase 3
Recruiting
- Conditions
- Pre-eclampsia.Pre-eclampsia
- Registration Number
- IRCT20120215009014N416
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 172
Inclusion Criteria
Age of 18 to 45 years;
Primiparous:
Singleton;
Gestational age of 20 weeks;
Exclusion Criteria
History of hypertension;
Affected with chronic diseases such as thyroid disorder and diabetes;
Using selenium supplement;
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Preeclampsia. Timepoint: Every two weeks until the end of pregnancy. Method of measurement: By taking a history (headache, blurred vision, epigastric pain, seizures), clinical examination (hypertension) and laboratory methods (oliguria, proteinuria, and increased liver enzymes).
- Secondary Outcome Measures
Name Time Method